Patients with mild cognitive impairment frequently take potentially inappropriate medications, highlighting a need for future research on whether reducing their use improves cognitive symptoms.
Patients with MCI are frequently taking PIMs that may negatively affect cognition. Future research is needed to assess whether cognitive impairment symptoms are improved if PIM use is reduced.
Weston et al. (Tue,) studied this question.